Joyce Teng, MD
Pediatric Dermatology · Palo Alto, CANPI 1801850854
Payments from drug & device makers
Across 426 payments — averaging $23,498 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$8.2M
- Amgen$934K
- Regeneron$235K
- Arcutis Biotherapeutics, Inc.$200K
- LEO Pharma AS$140K
- Pfizer$87K
- plus $169K from 18 others
Across 12 payments — averaging $490.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$4K
- AbbVie$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 36 | $8,245,249 |
| Amgen | 32 | $934,372 |
| Regeneron | 165 | $235,099 |
| Arcutis Biotherapeutics, Inc. | 38 | $200,208 |
| LEO Pharma AS | 48 | $139,585 |
| Pfizer | 23 | $86,524 |
| Incyte Corporation | 7 | $25,928 |
| Abeona Therapeutics, Inc. | 7 | $25,495 |
| Janssen Research & Development, LLC | 11 | $25,222 |
| Chiesi USA, Inc. | 13 | $18,732 |
| Amryt Pharma Holdings Ltd | 7 | $16,915 |
| Eli Lilly | 1 | $16,400 |
| Tanabe Pharma America, Inc. | 4 | $9,470 |
| Biocryst Pharmaceuticals, Inc. | 4 | $6,181 |
| Pierre Fabre Pharmaceuticals, Inc. | 8 | $5,895 |
| Nobelpharma America, LLC | 6 | $5,262 |
| Novartis Pharma AG | 1 | $4,000 |
| Ipsen Biopharmaceuticals, Inc | 2 | $3,885 |
| LEO Pharma Inc. | 4 | $3,121 |
| Mitsubishi Tanabe Pharma Holdings America, Inc. | 1 | $1,240 |
| Bristol Myers Squibb | 2 | $1,040 |
| Solta Medical, A Division Of Bausch Health US, LLC | 2 | $207 |
| Regeneron Healthcare Solutions, Inc. | 1 | $134 |
| Krystal Biotech Inc | 3 | $55 |
How this compares
$10,010,220 in reported general payments places this provider in the 95th percentile of 36 pediatric dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pediatric dermatology in Palo Alto
- Shireen GuidePalo Alto$569K
- Ilka NetravaliPalo Alto$26K
- Dawn SiegelPalo Alto$12K
- Amy GilliamPalo Alto$3K
- Ann MarquelingPalo Alto$243
- Chaw-Ning LeePalo Alto$31
- Lawrence EichenfieldSan Diego$3.4M
- Wynnis TomSan Diego$533K
- Dawn EichenfieldSan Diego$320K
- Smita AwasthiSacramento$140K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.